[ Price : $8.95]
Constellation Pharmaceuticals and the Leukemia & Lymphoma Society enter into a partnership to develop a BET inhibitor for treating...[ Price : $8.95]
FDA approves a SPR Therapeutics Investigational Device Exemption to initiate a study of its SMARTPATCH Peripheral Nerve Stimulatio...[ Price : $8.95]
The National Cancer Institute contracts with Eutropics Pharmaceuticals for a Phase 2 commercial development of a diagnostic assay ...[ Price : $8.95]
FDA senior policy advisor and chief negotiator Peter Beckerman tells a user fee conference that increased resources for regular su...[ Price : $8.95]
Ten of the top biopharmaceutical companies join forces to improve clinical trial quality and speed drugs to patients.[ Price : $8.95]
FDA says it will not revoke approval for OxyContin labeling and call it misleading.[ Price : $8.95]
AstraZeneca breaks an education program for coronary patients taking Brilinta.[ Price : $8.95]
Researchers comparing four different methodologies for pharmacokinetic and pharmacodynamic testing of the anti-melanoma agent carb...